Designated as an emerging epidemic in 1997, heart failure (HF) remains a major clinical
and public health problem. This review focuses on the most recent studies identified by …

Aims The aim of the present paper was to provide an up‐to‐date view on epidemiology and
risk factors of heart failure (HF) development after myocardial infarction. Methods and results …

The burden of heart failure (HF), developing after myocardial infarction MI, still represents a
major issue in clinical practice. Failure of appropriate resolution of inflammation during post …

Improvements in early interventions after acute myocardial infarction (AMI), notably, the
increased use of timely reperfusion therapy, have increased survival dramatically in recent …

Myocardial infarction (MI), as a result of thrombosis or vascular occlusion, is the most
prevalent cause of morbidity and mortality among all cardiovascular diseases. The …

Background Large-scale and contemporary population-based studies of heart failure
incidence are needed to inform resource planning and research prioritisation but current …

Heart failure is the most common cardiovascular reason for hospital admission for people
older than 60 years of age. Few areas in medicine have progressed as remarkably as heart …

Importance Heart failure (HF) is commonly referred to as an epidemic, posing major clinical
and public health challenges. Yet, contemporary data on its magnitude and implications are …

Aims Clinical features and outcomes in the novel phenotype heart failure with mid‐range
ejection fraction [HFmrEF, ejection fraction (EF) 40–49%] were compared with heart failure …

Aims Whether prevalence and mortality of patients with heart failure with preserved or mid-
range (40–49%) ejection fraction (HFpEF and HFmREF) are similar to those of heart failure …